Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dyslipidaemia in nephrotic syndrome: mechanisms and treatment
Shipra Agrawal, Joshua J. Zaritsky, Alessia Fornoni, et al.
Nature Reviews Nephrology (2017) Vol. 14, Iss. 1, pp. 57-70
Open Access | Times Cited: 269

Showing 1-25 of 269 citing articles:

KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, et al.
Kidney International (2021) Vol. 100, Iss. 4, pp. S1-S276
Open Access | Times Cited: 1556
Podocytopathies
Jeffrey B. Kopp, Hans‐Joachim Anders, Katalin Suszták, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 362
Membranous nephropathy
Pierre Ronco, Laurence H. Beck, Hanna Dêbiec, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 284
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome
Agnes Trautmann, Marina Vivarelli, Susan Samuel, et al.
Pediatric Nephrology (2020) Vol. 35, Iss. 8, pp. 1529-1561
Open Access | Times Cited: 268
Signaling pathways of chronic kidney diseases, implications for therapeutics
Qian Yuan, Ben Tang, Chun Zhang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 225
Lipid management in patients with chronic kidney disease
Charles J. Ferro, Patrick B. Mark, Mehmet Kanbay, et al.
Nature Reviews Nephrology (2018) Vol. 14, Iss. 12, pp. 727-749
Open Access | Times Cited: 208
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
Tomonori Okamura, Kazuhisa Tsukamoto, Hidenori Arai, et al.
Journal of Atherosclerosis and Thrombosis (2023) Vol. 31, Iss. 6, pp. 641-853
Open Access | Times Cited: 138
The key role of altered tubule cell lipid metabolism in kidney disease development
Lauren E. Lee, Tomohito Doke, Dhanunjay Mukhi, et al.
Kidney International (2024) Vol. 106, Iss. 1, pp. 24-34
Open Access | Times Cited: 24
Disorders of Lipid Metabolism in Chronic Kidney Disease
Mustafa C. Bulbul, Tuncay Dağel, Barış Afşar, et al.
Blood Purification (2018) Vol. 46, Iss. 2, pp. 144-152
Open Access | Times Cited: 128
Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease
Asier Benito‐Vicente, Kepa B. Uribe, Shifa Jebari, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3426-3426
Open Access | Times Cited: 113
Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases
Xiaopeng Ai, Peiling Yu, Li‐Xia Peng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 97
Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)
Jih-Kai Huang, Hsiang‐Chun Lee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4300-4300
Open Access | Times Cited: 56
B cell-derived anti-beta 2 glycoprotein I antibody mediates hyperhomocysteinemia-aggravated hypertensive glomerular lesions by triggering ferroptosis
Xing Du, Xiaolong Ma, Ying Tan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 27
Nephrotic syndrome: pathophysiology and consequences
Claudio Ponticelli, Moroni Gabriella
Journal of Nephrology (2023) Vol. 36, Iss. 8, pp. 2179-2190
Closed Access | Times Cited: 25
Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis
Cheuk Yin Wong, M Y Becky, Danting Zhang, et al.
Lupus Science & Medicine (2024) Vol. 11, Iss. 1, pp. e001152-e001152
Open Access | Times Cited: 9
High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend or Foe?
Ke Liu, Mark E. Cooper, Zhonglin Chai, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1683-1683
Open Access | Times Cited: 1
Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD
Archna Bajaj, Dawei Xie, Esteban Cedillo-Couvert, et al.
American Journal of Kidney Diseases (2019) Vol. 73, Iss. 6, pp. 827-836
Open Access | Times Cited: 65
Secondary Membranous Nephropathy. A Narrative Review
Gabriella Moroni, Claudio Ponticelli
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 65
Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long‐term inhibition
Arturo Cesaro, Vanessa Bianconi, Felice Gragnano, et al.
BioFactors (2020) Vol. 46, Iss. 3, pp. 367-380
Closed Access | Times Cited: 58
Emerging insights into the relationship between hyperlipidemia and the risk of diabetic retinopathy
Yuyu Chou, Jin Ma, Xin Su, et al.
Lipids in Health and Disease (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 52
Secondary dyslipidemia: its treatments and association with atherosclerosis
Hidekatsu Yanai, Hiroshi Yoshida
Global Health & Medicine (2020) Vol. 3, Iss. 1, pp. 15-23
Open Access | Times Cited: 51
Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis
Patricia Hernández, Neena Passi, Taher Modarressi, et al.
Current Atherosclerosis Reports (2021) Vol. 23, Iss. 11
Open Access | Times Cited: 43
An update on LDL apheresis for nephrotic syndrome
Rupesh Raina, Vinod Krishnappa
Pediatric Nephrology (2018) Vol. 34, Iss. 10, pp. 1655-1669
Closed Access | Times Cited: 58
Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Proteomics
Shipra Agrawal, Michael L. Merchant, Jiro Kino, et al.
Kidney International Reports (2019) Vol. 5, Iss. 1, pp. 66-80
Open Access | Times Cited: 48
Lipoproteins in chronic kidney disease: from bench to bedside
Thimoteus Speer, Paul M. Ridker, Arnold von Eckardstein, et al.
European Heart Journal (2020) Vol. 42, Iss. 22, pp. 2170-2185
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top